Psyence Biomedical (PBM) Long-Term Investments (2025)
Psyence Biomedical (PBM) recorded quarterly Long-Term Investments of $5.2 million in Q3 2025, up 594.23% quarter-over-quarter from $745000.0 in Q1 2025.
Psyence Biomedical (PBM) Long-Term Investments (2025) Analysis & Trends
Psyence Biomedical's Long-Term Investments history runs 1 years deep, the most recent figure standing at $5.2 million for Q3 2025.
- In Q3 2025, Long-Term Investments changed N/A year-over-year to $5.2 million; the TTM figure through Sep 2025 stood at $5.2 million (changed N/A YoY), while the FY2025 annual figure was $745000.0, changed N/A from the prior year.
- Long-Term Investments was $5.2 million for Q3 2025 at Psyence Biomedical, up from $745000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $5.2 million in Q3 2025 to a low of $745000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 9.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 745,000.00 |